1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Graft-versus-host disease (GVHD) after double-unit cord blood transplantation (DCBT) is associated with unique clinical features including a higher incidence of grade III-IV acute GVHD in children
    Meeting Abstract

    Ponce, D. M.; Gonzales, A. M.; Lubin, M. N.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; van den Brink, M. R. M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • FTY720 restores PP2A tumor suppressor activity in polycythemia vera CD34(+) progenitors through inhibition of jak2 V617F-and PI-3K gamma-dependent SET serine phosphorylation and enhancement of NOS-dependent PP2A tyrosine nitration
    Meeting Abstract

    Oaks, J. J.; Mukhopadhyay, A.; Santhanam, R.; Saddoughi, S. A.; Neviani, P.; Harb, J. G.; Ogretmen, B.; Bittman, R.; Levine, R. L.; Quintas-Cardama, A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Evaluating clonal dominance in a murine knock-in model of jak2V617F MPN
    Meeting Abstract

    Mullally, A.; Poveromo, L.; Brumme, K.; Al-Shahrour, F.; Lane, S. W.; Shih, A. H.; Aifantis, I.; Levine, R. L.; Ebert, B. L.
    Blood (2011)

    Fulltext@MSK | Save
  • In vivo RNA interference screening identifies a leukemia-specific dependence on integrin beta 3 signaling
    Meeting Abstract

    Miller, P.; Al-Shahrour, F.; Hartwell, K. A.; Chu, L. P.; Marcus, J.; Puram, R. V.; Puissant, A.; Callahan, K.; Ashton, J. M.; McConkey, M. E.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome
    Meeting Abstract

    Manshouri, T.; Estrov, Z.; Knez, L.; Zhang, Y.; Levine, R. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Regulation of cytoplasmic dynein in T cell activation-induced microtubule-organizing center (MTOC) reorientation
    Meeting Abstract

    Liu, X.; Quann, E. J.; Huse, M.
    Molecular Biology of the Cell (2011)

    Fulltext@MSK | Save
  • Msi2 maintains normal hematopoietic stem cell self-renewal
    Meeting Abstract

    Kharas, M. G.; Lengner, C.; Al-Shahrour, F.; Ebert, B. L.; Daley, G. Q.
    Blood (2011)

    Fulltext@MSK | Save
  • Inhibition of AKT signaling potently inhibits the growth of JAK and MPL-mutant cells in the myeloproliferative neoplasms in vitro and in vivo
    Meeting Abstract

    Khan, I.; Huang, Z.; Wen, Q. J.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save
  • Increased MSI2 expression is associated with aggressive CML and AML
    Meeting Abstract

    Kaeda, J. S.; Mills, K. I.; Kharas, M. G.; Saglio, G.; Schwarz, M.; Oberender, C.; Pawlaczyk-Peter, B.; van Lessen, A.; Tuurkmen, S.; Baldus, C. D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save